By combining ASI’s imaging and analysis solutions with Zytomics’ reagents, automation and analytics, the companies aim at creating more integrated and scalable solutions for pathology and cytogenetics laboratories.
Immunohistochemical (IHC) diagnostics play an important role in the diagnosis of prostate cancer, particularly in differentiating between benign and malignant prostate diseases and in determining the type of tumor. Prostate cancer is the most common cancer in men in Germany, accounting for 26% of all cancers.
Selecting your region and language ensures you receive the corresponding product portfolio and contact details.
Country / Region
Language
Cookie Settings
We use cookies to give you the best experience on our website. You can choose which cookies you want to allow below. You can find more details in our privacy policy.
Essential cookies are cookies that are needed for the proper functioning of the website.
If selected, your visit on this website If selected, your visit to this website will be recorded by Matomo web analytics. The data collected will not be passed on to third parties.